RMC No. 3-2019: Official Guidance on Inter-Agency VAT Refund Claims in the Philippines

RMC No. 3-2019 circulates Joint Circular No. 001-2018 on VAT refund claims, guiding BIR personnel and taxpayers on inter-agency refund compliance. Businesses pursuing VAT refund claims should treat RMC No. 3-2019 as an official notice that the inter-agency rules on VAT refunds under Joint Circular No. 001-2018 are now being circulated for the guidance of […]

RMO No. 2-2019: TIN Card BIR Form 1931 Declared an Accountable Form to Control Fake TIN Cards

RMO No. 2-2019 makes the redesigned TIN Card BIR Form 1931 an accountable form with serial-number control to combat fake TIN Cards. Businesses, employers, HR departments, accountants, and taxpayers should expect tighter control over the issuance of TIN Cards because the BIR has declared the redesigned TIN Card, BIR Form No. 1931, as an accountable […]

RMC No. 2-2019: VAT Exemption on Diabetes, High-Cholesterol and Hypertension Drugs in the Philippines

RMC No. 2-2019 implements VAT exemption for FDA-listed diabetes, high-cholesterol, and hypertension drugs, with EDPMS and price reporting rules. Drug manufacturers, distributors, wholesalers, retailers, hospital pharmacies, and other FDA-licensed establishments must apply VAT exemption only to qualified diabetes, high-cholesterol, and hypertension medicines in final form, and only when those medicines are included in the FDA-published […]